UK Companies House feature
NOVARTIS PHARMACEUTICALS UK LIMITED
Profile
- Company number
- 00119006
- Status
- Active
- Incorporation
- 1911-12-08
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have considered the financial position of the company as at the balance sheet date, including the net assets of £144,450,000 and net current assets of £101,907,000. The company also has a broad customer base, and a strong history of profitable operations. There are no indications that this will not continue to be the case through the foreseeable future. Noting the considerable financial resources available to the company, alongside the company's access to Novartis's global cash pooling arrangement, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, covering a period of at least 12 months from the issue of the financial statements. Therefore, they have prepared the financial statements on the going concern basis.”
Subsidiaries
- Neutec Pharma Limited · 100% held · UK · Non-trading
Significant events
- “On 14 December 2024, board of directors of Gyroscope Therapeutics Limited (a Novartis Group company in UK) decided to transfer it's business with the exception of the office lease to Novartis Pharmaceuticals UK Limited. The agreement to transfer Gyroscope's residual activities to Novartis Pharmaceuticals UK Limited was resolved on 14 December 2024 and signed on 17 June 2025.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 61 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CULLEN, Richard Samuel | Secretary | 2026-01-01 | — | — |
| GUPTA, Sandeep | Director | 2025-05-12 | Jun 1982 | Indian |
| KAHLSTROEM, Johan Mikael Olof | Director | 2024-11-01 | Jul 1980 | Swedish |
Show 61 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLSUP, Valerie | Secretary | 1997-06-05 | 2000-03-01 |
| CULLEN, Richard Samuel | Secretary | 2021-01-01 | 2022-07-20 |
| HOLGATE, Benjamin James Michael | Secretary | 2011-06-22 | 2016-01-31 |
| JENNINGS, Sally Jane | Secretary | 2000-12-31 | 2008-03-11 |
| ROBERTS, Helen | Secretary | 2008-03-11 | 2011-06-22 |
| ROBINSON, Timothy William | Secretary | 2022-07-20 | 2026-01-01 |
| SHORTHOSE, Sally Jane | Secretary | 2000-03-01 | 2000-12-31 |
| THIRKETTLE, Paul Richard Edward | Secretary | — | 1997-06-05 |
| WESTON, Rebecca Ann | Secretary | 2016-02-01 | 2021-01-01 |
| ADAMS, Adrian | Director | 1999-04-30 | 2001-06-08 |
| AHMAD, Haseeb | Director | 2017-03-28 | 2021-04-01 |
| ARROCHA, Edgar Humberto | Director | 2014-08-26 | 2016-08-15 |
| ASHTON, David Thomas | Director | 2001-01-23 | 2001-09-27 |
| BARLOCHER, Urs, Dr | Director | 1993-05-20 | 1995-10-01 |
| BATZER, Martin Christopher, Dr | Director | 1995-10-01 | 1997-02-13 |
| BHATT, Chinmay Umesh | Director | 2020-09-01 | 2022-05-31 |
| BRANDLI, Reto Ernst | Director | 2000-01-28 | 2006-03-01 |
| BRAZIER, Richard John | Director | 2006-02-22 | 2009-07-01 |
| BREU, Raymund, Dr | Director | 2000-12-11 | 2010-03-31 |
| BROOKS, Jason Mark | Director | 2019-05-09 | 2025-04-08 |
| CHARHON, Jean-Jacques | Director | 2006-03-01 | 2007-05-15 |
| CORNUT, Eric, Dr | Director | 2007-02-01 | 2013-01-24 |
| CUMMINS, Gordon John | Director | 2004-05-20 | 2006-02-01 |
| FAHEY, Michael John | Director | 2001-11-30 | 2004-05-20 |
| FULLAGAR, Edgar | Director | 1997-04-07 | 2002-04-23 |
| FULLAGAR, Edgar | Director | — | 1994-07-01 |
| GABRIEL, Silvio | Director | 2001-02-01 | 2005-03-16 |
| GAMACHE, Marie-Andree Renee | Director | 2022-06-29 | 2024-10-31 |
| GUERARD, Frederic Marcel Benoit | Director | 2012-09-06 | 2015-03-31 |
| GUIDI, Guido Angelo Giovanni | Director | 2013-01-24 | 2017-01-18 |
| HANTSON, Ludwig Norbert Michel, Dr | Director | 2005-03-21 | 2007-02-01 |
| JOSE, Teresa | Director | 2009-07-01 | 2012-04-03 |
| KAPADIA, Sandipkumar Shantilal | Director | 2012-04-03 | 2014-08-26 |
| KINDLER, Hans | Director | 1997-04-24 | 2000-12-11 |
| KIRSCH, Harry Werner | Director | 2013-06-20 | 2018-07-10 |
| KREISSIG, Roland | Director | 2021-12-14 | 2022-05-31 |
| KROPS, Eduard Gerhard | Director | 1993-05-01 | 1993-08-26 |
| LACAZE, Oriane Fanny | Director | 2016-08-15 | 2019-05-09 |
| LINK, Max | Director | — | 1993-08-26 |
| METCALFE, Richard | Director | 1993-02-01 | 1997-12-31 |
| O'DOWD, Hugh Michael | Director | 2015-03-31 | 2016-09-16 |
| PALACHI, Barak Avraham | Director | 2017-05-14 | 2018-03-19 |
| PARIS, William Drummond | Director | 2001-09-14 | 2005-04-22 |
| PRAT, Lluis | Director | 2007-05-22 | 2016-03-10 |
| RACLOZ, Jacques | Director | 1994-07-01 | 1997-10-31 |
| RANG, Humphrey Peter, Professor | Director | 1992-06-01 | 1997-04-07 |
| REINHARDT, Joerg | Director | 1999-01-26 | 2005-03-21 |
| SAXENA, Subhanu | Director | 2005-04-22 | 2009-08-26 |
| SCHEIFFELE, Anna Mari, Dr | Director | 2018-05-09 | 2021-10-31 |
| SCHILLINGER, Erwin, Dr | Director | 1992-09-01 | 1993-05-01 |
| SCHLIENGER, Peter | Director | 1992-09-01 | 1995-10-01 |
| SNOOK, Christopher David | Director | 2016-03-10 | 2017-05-31 |
| SOIRON, Rolf | Director | — | 1993-05-20 |
| STROPPEL, Stefan Hans | Director | 1998-01-19 | 2001-01-23 |
| SYMON, John | Director | 1997-11-06 | 1999-08-31 |
| SYMONDS, Jonathan Richard | Director | 2010-03-31 | 2013-06-20 |
| TSCHUDIN, Marie-France | Director | 2017-01-18 | 2019-05-22 |
| VASELLA, Daniel | Director | 1995-10-01 | 1997-02-13 |
| WACK, Rene | Director | — | 1992-12-31 |
| WEBB, Susan Ann | Director | 2009-08-26 | 2012-09-06 |
| YOUMANS, James Clifford | Director | 1997-04-24 | 1997-06-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Novartis Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 251 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-01-05 | AP03 | officers | appoint person secretary company with name date |
| 2026-01-05 | TM02 | officers | termination secretary company with name termination date |
| 2025-10-03 | AA | accounts | accounts with accounts type full |
| 2025-05-13 | AP01 | officers | appoint person director company with name date |
| 2025-04-17 | TM01 | officers | termination director company with name termination date |
| 2025-04-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-01-14 | CH01 | officers | change person director company with change date |
| 2024-11-05 | AP01 | officers | appoint person director company with name date |
| 2024-11-04 | TM01 | officers | termination director company with name termination date |
| 2024-08-06 | AA | accounts | accounts with accounts type full |
| 2024-04-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-12 | AA | accounts | accounts with accounts type full |
| 2023-09-01 | CH01 | officers | change person director company with change date |
| 2023-04-04 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-09-26 | AA | accounts | accounts with accounts type full |
| 2022-08-16 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2022-07-26 | AP03 | officers | appoint person secretary company with name date |
| 2022-07-25 | TM02 | officers | termination secretary company with name termination date |
| 2022-07-05 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory